ELIZABETH FRIDRICH: Open Payments
NPI 1700176500 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 26 payments from 9 companies in 2025. Trend: 2023 $186 · 2024 $202 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $122 |
| Novo Nordisk Inc | 5 | $92 |
| PFIZER INC. | 3 | $45 |
| Exact Sciences Corporation | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: MOUNJARO, Wegovy, NURTEC ODT, Ozempic, The Cologuard Plus Collection Kit, LEQVIO, CAMZYOS, JARDIANCE.
Industry payments across ND — which companies pay providers there.
